Indian markets show mixed momentum as major pharma firms launch generic semaglutide following patent expiration, while banking and tech sectors drive dealmaking activity. Seven drugmakers including Sun Pharmaceuticals, Dr Reddy's, and Torrent Pharma entered the semaglutide market, potentially reshaping the obesity and diabetes treatment landscape. Meanwhile, State Bank of India faces a Rs 6,337.5 crore income tax demand notice but maintains operations remain unaffected. Kotak Mahindra Bank's subsidiary divested a 30.99 percent stake in Infina Finance for Rs 1,294 crore. Tech giants Wipro and Infosys accelerated AI initiatives with new solutions targeting enterprise adoption and fan engagement respectively. The SENSEX gained 325.72 points to close at 74,532.96 while NIFTY added 112.35 points at 23,114.50. Crude oil surged 251 points amid global demand concerns.
